Cancer in anaesthesia perspective
Cancer represents a significant global health burden. In 2020, an estimated 19.3 million new cancer cases were reported worldwide, accompanied by nearly 10 million cancer-related deaths. Projections indicate that the incidence of cancer could rise to 28.4 million cases by 2040.1 Surgical resection i...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Malaysian Society of Anaesthesiologists
2024
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/116446/13/116446_Cancer%20in%20Anaesthesia%20perspective.pdf http://irep.iium.edu.my/116446/ https://www.msa.net.my/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Cancer represents a significant global health burden. In 2020, an estimated 19.3 million new cancer cases were reported worldwide, accompanied by nearly 10 million cancer-related deaths. Projections indicate that the incidence of cancer could rise to 28.4 million cases by 2040.1 Surgical resection is widely regarded as the primary treatment modality for solid malignant tumours. However, postsurgical cancer recurrence and metastasis remain the leading causes of cancer related mortality.2 Emerging evidence suggests that anaesthetic agents used during surgical ptrocedures may disrupt the delicate balance between tumour aggressiveness and the body’s immune surveillance, thereby contributing to cancer recurrence and metastasis. Consequently, it is imperative to identify the optimal anaesthetic agents for patients undergoing oncologic surgery |
|---|